Cargando…

Comparative effectiveness of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a network meta-analysis of randomized controlled studies

BACKGROUND: There is evidence demonstrating the beneficial effects of 5-hydroxytryptamine 3 receptor antagonists (5-HT(3)) for the treatment of non-constipated irritable bowel syndrome (NC-IBS). We aimed to determine the comparative effectiveness of 5-HT(3) antagonists in NC-IBS, as evidenced by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rokkas, Theodore, Ekmektzoglou, Konstantinos, Niv, Yaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276363/ https://www.ncbi.nlm.nih.gov/pubmed/34276193 http://dx.doi.org/10.20524/aog.2021.0619

Ejemplares similares

Current role of narrow band imaging in diagnosing gastric intestinal metaplasia: a systematic review and meta-analysis of its diagnostic accuracy
por: Rokkas, Theodore, et al.
Publicado: (2023)

Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials
por: Zheng, Yongping, et al.
Publicado: (2017)

Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015)

Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure
por: Chen, Yuting, et al.
Publicado: (2021)

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.
por: Bermudez, J., et al.
Publicado: (1988)

Effective treatment with combination of peripheral 5‐hydroxytryptamine synthetic inhibitor and 5‐hydroxytryptamine 2 receptor antagonist on glucocorticoid‐induced whole‐body insulin resistance with hyperglycemia
por: Ma, Shaoxin, et al.
Publicado: (2016)

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
por: Palli, Swetha Rao, et al.
Publicado: (2015)

5- Hydroxytryptamine
por: Giarman, Nicholas J.
Publicado: (1958)

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
por: Boltin, Doron, et al.
Publicado: (2014)

The Effect of 5-Hydroxytryptamine Receptor Antagonist in Preventing Pain/Limb Shrinkage Reaction Associated with Rocuronium Injection
por: He, Qixiong, et al.
Publicado: (2018)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020)

Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
por: Arai, Toru, et al.
Publicado: (2022)

5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials
por: Pithadia, Anand B., et al.
Publicado: (2009)

Serotonin in the rat prefrontal cortex controls the micturition reflex through 5‐hydroxytryptamine 2A and 5‐hydroxytryptamine 7 receptors
por: Chiba, Hiroki, et al.
Publicado: (2020)

STORAGE OF 5-HYDROXYTRYPTAMINE IN MEGAKARYOCYTES
por: Tranzer, J. P., et al.
Publicado: (1972)

Novel Treatment of Ventilator Dyssynchrony From Central Alveolar Hypoventilation Syndrome Utilizing Scheduled 5-Hydroxytryptamine-3 Receptor Antagonist
por: Malkoc, Aldin, et al.
Publicado: (2022)

Ethanol Extract of Mao Jian Green Tea Attenuates Gastrointestinal Symptoms in a Rat Model of Irritable Bowel Syndrome with Constipation via the 5-hydroxytryptamine Signaling Pathway
por: Wu, Lei, et al.
Publicado: (2023)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Structure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor
por: Wang, Qing, et al.
Publicado: (2021)

Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT(3)) receptors in Metazoa
por: Rao, Santosh T. R. B., et al.
Publicado: (2023)

Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo in the treatment of patients with irritable bowel syndrome
por: Niv, E., et al.
Publicado: (2016)

Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis
por: Rokkas, Theodore
Publicado: (2020)

Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis
por: Yamamoto, Senri, et al.
Publicado: (2022)

Upregulation of 5-Hydroxytryptamine Receptor Signaling in Coronary Arteries after Organ Culture
por: Deng, Chun-Yu, et al.
Publicado: (2014)

The 5-hydroxytryptamine 4 Receptor Agonist-induced Actions and Enteric Neurogenesis in the Gut
por: Takaki, Miyako, et al.
Publicado: (2014)

5-Hydroxytryptamine (serotonin) 2A receptor gene polymorphism is associated with schizophrenia
por: Sujitha, Subash Padmajeya, et al.
Publicado: (2014)

The 5‐hydroxytryptamine(4) receptor enables differentiation of informational content and encoding in the hippocampus
por: Twarkowski, Hannah, et al.
Publicado: (2016)

Involvement of 5-Hydroxytryptamine Receptor 2A in the Pathophysiology of Medication-Overuse Headache
por: Zheng, Zhenyang, et al.
Publicado: (2021)

Dynamics and Patterning of 5-Hydroxytryptamine 2 Subtype Receptors in JC Polyomavirus Entry
por: Mehmood, Kashif, et al.
Publicado: (2022)

Possible Role of 5-Hydroxytryptamine (5-HT) Receptor on Human Sperm Motility Regulation
por: Omote, Maya, et al.
Publicado: (2023)

Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis
por: Zhu, Lingping, et al.
Publicado: (2018)

A Meta-Analysis of 5-Hydroxytryptamine Receptor 1B Polymorphisms With Risk of Major Depressive Disorder and Suicidal Behavior
por: Yang, Pingliang, et al.
Publicado: (2021)

Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol
por: Yang, Man, et al.
Publicado: (2019)

Depressive symptoms in patients with irritable bowel syndrome: a meta-analysis of comparative studies
por: Zhang, Qing-E, et al.
Publicado: (2018)

Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.
por: Miner, W. D., et al.
Publicado: (1987)

Remaining Need for In Vitro Test to Elucidate 5-Hydroxytryptamine 2C Receptor Functioning
por: Ivanova, Svetlana A., et al.
Publicado: (2018)

Physiological Control of Molluscan Gill Cilia by 5-Hydroxytryptamine
por: Gosselin, R. E., et al.
Publicado: (1962)

CHEMICAL AND ULTRASTRUCTURAL IDENTIFICATION OF 5-HYDROXYTRYPTAMINE IN AN IDENTIFIED NEURON
por: Rude, Sonia, et al.
Publicado: (1969)

The Mechanism of Secretion and Metabolism of Gut-Derived 5-Hydroxytryptamine
por: Liu, Ning, et al.
Publicado: (2021)

Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials
por: Eissazade, Negin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rkuc8rafvho8jcn4cs82smvilb